AkzoNobel share repurchase (April 3, 2017 - April 7, 2017)

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
75
AkzoNobel share repurchase (April 3, 2017 - April 7, 2017)

April 10, 2017

Akzo Nobel N.V. (AKZA.AS; AKZOY)

AkzoNobel has repurchased 106,200 of its own ordinary shares in the period from April 3, 2017 up to and including April 7, 2017, at an average price of €78.55 per share. The consideration of the repurchase was €8.34 million.

This is part of a repurchase program announced on December 12, 2016. The total number of shares repurchased under this program to date is 2.28 million ordinary shares for a total consideration of €151.99 million.

The purpose of the program is to neutralize the dilutive effect of stock dividends paid in 2016.

For more information, visit https://www.akzonobel.com/for-investors/share...k-overview

This is a press release by Akzo Nobel N.V. pursuant to Section 5, paragraph 4 of the Netherlands Decree on Public Takeover Bids.

- - -

AkzoNobel creates everyday essentials to make people's lives more liveable and inspiring. As a leading global paints and coatings company and a major producer of specialty chemicals, we supply essential ingredients, essential protection and essential color to industries and consumers worldwide. Backed by a pioneering heritage, our innovative products and sustainable technologies are designed to meet the growing demands of our fast-changing planet, while making life easier. Headquartered in Amsterdam, the Netherlands, we have approximately 46,000 people in around 80 countries, while our portfolio includes well-known brands such as Dulux, Sikkens, International, Interpon and Eka. Consistently ranked as a leader in sustainability, we are dedicated to energizing cities and communities while creating a protected, colorful world where life is improved by what we do.

Not for publication - for more information

Corporate Media Relations Corporate Investor Relations
T +31 (0)88 - 969 7833 T +31 (0)88 - 969 7590
Contact: Andrew Wood Contact: Lloyd Midwinter

                                                                                               

Safe Harbor Statement This press release contains statements which address key issues such as AkzoNobel's growth strategy, future financial results, market positions, product development, products in the pipeline and product approvals. Such statements should be carefully considered, and it should be understood that many factors could cause forecasted and actual results to differ from these statements. These factors include, but are not limited to, price fluctuations, currency fluctuations, developments in raw material and personnel costs, pensions, physical and environmental risks, legal issues, and legislative, fiscal, and other regulatory measures. Stated competitive positions are based on management estimates supported by information provided by specialized external agencies. For a more comprehensive discussion of the risk factors affecting our business please see our latest annual report, a copy of which can be found on our website: www.akzonobel.com .   

Attachments:

http://www.globenewswire.com/NewsRoom/Attachm...e2ea89ac04

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Debbie's Dream Foundation Launches 2026 Youth Art Contest

Updated Category News Views 5

Young Artists Called to Inspire a Cancer-Free World What's the first image that pops into your head when you think of a world free from cancer? That's the magic question on deck for this year's Youth Art Contest by Debbie's Dream Foundation. Imaginations are set to run wild as the competition opens its gates to artists under 18, calling for visions splashed across...

Continue Reading
California Accelerates AI Law with Newsom's Bold Move

Updated Category News Views 3

Pushing AI Regulations into High Gear I'll tell you what—it's about time somebody shook things up in the AI world with more than empty promises. Governor Newsom's executive order is doing just that, fast-tracking the timeline for implementing California's SB 813. This move is like giving speed boots to the legislative process, revving up the rules to ensure AI doesn't...

Continue Reading
AI Agents Challenge Product Governance Models

Updated Category News Views 6

AI's Increasing Role: A Double-Edged Sword for Leaders Hey, the tech overlords remind us once again—the future doesn't wait for anyone to catch up before it bulldozes forward. Info-Tech Research Group has sounded the alarm on AI agents muscling their way into product decisions without any clear nod from the human corner office. Blurring Lines of Accountability The...

Continue Reading
Vetology Reinvents AI Models for Veterinary Radiology

Updated Category News Views 6

Revamping AI in Veterinary Practices Out there in San Diego, Vetology's been rolling up its sleeves and getting down to brass tacks with a complete do-over of their AI classifiers. They’ve rebuilt all 94 of them, every last one, on a brand-new architecture. No small task, this overhaul stretched from June to August and it wasn't just paint and polish but a whole new...

Continue Reading
Menopause Policy Advocacy Takes Center Stage in DC

Updated Category News Views 5

Unlikely Spotlight on Menopause at Capitol Hill If you told me a couple of years back that menopause would become a front-page political issue, I would've laughed. Yet, here we are, with over 125 advocates from 29 states converging on Washington, D.C., demanding legislative action on menopause. Why Menopause Matters in Policy The fact that more than half the population is...

Continue Reading
Bellissima Bags Allure Award for Curly Hair Tool

Updated Category News Views 4

Award-Winning Tool Headlines 2026 Beauty Scene There's a shake-up in the world of hair tools, folks. Bellissima's Diffon Supreme has snagged a 2026 Allure Best of Beauty Award for its prowess in taming the curly, wavy, and coily strands we all crave to manage. Performance Meets Innovation in Bellissima's Latest Let's not beat around the bush. The Diffon Supreme's trump...

Continue Reading
Crimson Coward's Cheez Nugs Shake Up Fast-Casual Scene

Updated Category News Views 7

New Kid on the Block: Cheez Nugs Buckle up folks, Crimson Coward is at it again. They're rolling out something they claim will blow your taste buds straight out of the water: Cheez Nugs. Dropping nationwide on September 18, 2026, these aren't your run-of-the-mill cheese bites. We're talking 100% whole-milk mozzarella, a golden herb-seasoned crust, and a mouthful of creamy...

Continue Reading
FOSSI Opens 2027 Applications for Future STEM Leaders

Updated Category News Views 3

Paving Pathways in the Chemical Industry There's something brewing that's got me eyeing the future with cautious optimism, and it doesn't involve hedge funds or earnings reports. It's the Future of STEM Scholars Initiative (FOSSI) playing its cards just right, planting seeds for tomorrow's innovators. This puppy opened the gates for 2027 applications, and for young brains...

Continue Reading
Debt Crisis Looms: Social Security at Risk

Updated Category News Views 4

Debt Reality: A National Concern with Global Implications When it comes to the U.S. federal debt situation, the latest report from the National Seniors Policy Center is lighting a fire like no other, warning us that we're not crying wolf here. We've got fiscal numbers that may not sit well at breakfast. With roughly 67 cents of every new buck Uncle Sam borrows going to...

Continue Reading
ETERC's Ele Aims to Revolutionize STEM Education for All

Updated Category News Views 6

The AI Mentor Battleground in Education Ever found yourself wondering how public schools could step up their game without dumping money down the tech rabbit hole? ETERC’s latest push with Ele may just be a game-changer for them. We're not talking about your run-of-the-mill chatbot regurgitating facts from the internet—this is an AI tricked out for personalized...

Continue Reading

Top 5 Most Recently Viewed Articles

Dynacor Group Announces Monthly Dividend Payment for Shareholders

Updated Category News Views 143

Dynacor Group Declares Monthly Dividend Payments DYNACOR GROUP INC. (TSX: DNG) has announced a dividend payment for its shareholders that reflects the company's commitment to rewarding its investors. For the upcoming month, the company will distribute a dividend of C$0.01333 per common share, illustrating a steady financial approach. Dividend Details and Eligibility The...

Continue Reading
Cereno Scientific Expands CS014 Focus to Combat PH-ILD

Updated Category News Views 102

Cereno Scientific Expands CS014 Focus to Combat PH-ILD Cereno Scientific, a pioneering biotech company, has made a significant announcement regarding the development focus of its HDAC inhibitor CS014. This innovative treatment is now targeting pulmonary hypertension associated with interstitial lung disease (PH-ILD), an area marked by a high level of unmet medical need....

Continue Reading
Enlight Launches Tapolca Solar Facility, Boosting Capacity in Hungary

Updated Category News Views 204

Enlight Announces the Start of Commercial Operations at the Tapolca Solar Project The Tapolca solar project features an impressive capacity of 60 MW, with a total investment of $48 million dedicated to its construction. This project marks Enlight's fifth initiative in Hungary, boosting the Company's total operational generation capacity in the country to 144 MW. TEL AVIV,...

Continue Reading
Swvl Expands Its Operations into Europe with SaaS Contract

Updated Category News Views 183

Swvl's Entry into the European Market with SaaS Swvl is thrilled to announce its expansion into the European market with the launch of its Software as a Service (SaaS) offerings in the United Kingdom. This significant milestone not only marks Swvl's first enterprise contract in Europe but also indicates the Company’s strategic direction in adapting its revolutionary...

Continue Reading
NewAmsterdam Pharma's Insights at the Virtual Cardiometabolic Forum

Updated Category News Views 102

NewAmsterdam Pharma's Upcoming Presentation NewAmsterdam Pharma Company N.V. (NASDAQ: NAMS) is gearing up for an exciting participation at the renowned Stifel 2025 Virtual Cardiometabolic Forum. The company, well-regarded for its late-stage development of oral non-statin medicines for cardiovascular disease (CVD), is set to feature prominently in discussions aimed at...

Continue Reading